COYA
Coya Therapeutics, Inc. Common Stock
NASDAQ: COYA · HEALTHCARE · BIOTECHNOLOGY
$4.07
-4.46% today
Updated 2026-04-29
Market cap
$95.47M
P/E ratio
—
P/S ratio
12.02x
EPS (TTM)
$-1.27
Dividend yield
—
52W range
$4 – $8
Volume
0.1M
Coya Therapeutics, Inc. Common Stock (COYA) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-267.10%
Operating margin
-107.50%
ROE
-51.40%
ROA
-26.90%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2020 | — | $-1.10M | — | — | — |
| 2021 | $0.00 | $-4.89M | — | — | — |
| 2022 | $0.00 | $-12.24M | — | — | — |
| 2023 | $6.00M | $-7.99M | 8.34% | -131.67% | -133.08% |
| 2024 | $3.55M | $-14.88M | -233.86% | -485.35% | -418.70% |
| 2025 | $7.95M | $-21.23M | 99.66% | -255.05% | -267.14% |